Skip to main content
. 2017 Mar 6;8(17):28116–28124. doi: 10.18632/oncotarget.15922

Figure 5. In vivo experiments performed on rats.

Figure 5

(A) Relative tumour volume demonstrated that PARP1-i enhanced the effectiveness of cDDP-based thermochemotherapy and reduced the in vivo tumour outgrowth. Arrows present the time of treatment. (B) Time needed to achieve ten times the start volume (T10 × SV). Animals treated with the triple modality showed a delay in reaching T10 × SV compared to thermochemotherapy or any single treatment. All animal experiments included at least five rats per group.